(Q37798163)

23 August 2017

title

ANCA-associated vasculitides--advances in pathogenesis and treatment (English)

1 reference

23 August 2017

0 references

2

Cees G M Kallenberg

1 reference

23 August 2017

Min Chen

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

5 October 2010

1 reference

Nature Reviews Rheumatology

23 August 2017

published in

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

653-664

1 reference

Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Wegener Granulomatosis: An Analysis of 158 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Evaluation of a new algorithm in classification of systemic vasculitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Complex genetics of Wegener granulomatosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

An update of the HLA genomic region, locus information and disease associations: 2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Occupational exposure in ANCA-positive patients: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Staphylococcus aureus and Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "autoimmunity and infection".

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Neutrophils and drug metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

ANCA-associated renal vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Membrane expression of proteinase 3 is genetically determined

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Netting neutrophils in autoimmune small-vessel vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

From T to B and back again: positive feedback in systemic autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Cellular immunity in Wegener's granulomatosis: characterizing T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

The Th1 and Th2 Paradigm in ANCA-Associated Vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

The inflammatory Th 17 subset in immunity against self and non-self antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

EULAR recommendations for the management of primary small and medium vessel vasculitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Etanercept plus standard therapy for Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Predictors of survival and organ damage in Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.158

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis

31 March 2020

1 reference

12 December 2020

A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis

1 reference

12 December 2020

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group

1 reference

12 December 2020

Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils

1 reference

12 December 2020

ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.

1 reference

12 December 2020

Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis

1 reference

12 December 2020

Silica-induced apoptosis in alveolar and granulomatous cells in vivo

1 reference

12 December 2020

Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro

1 reference

12 December 2020

Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2010.158

1 reference

release_mxwiy6smknhpngmfgdecudygjq

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mxwiy6smknhpngmfgdecudygjq

24 November 2022

mapped directly with Wikidata item

1 reference